Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A<sub>4</sub> Mimetics (QNX-sLXms).

导出 OA

翻译打印收藏纠错

第一作者： Monica,de Gaetano

第一单位： School of Medicine, Diabetes Complications Research Centre, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland.

作者： Monica,de Gaetano ^[1] ; Catherine,Tighe ^[2] ; Kevin,Gahan ^[2] ; Andrea,Zanetti ^[2] ; Jianmin,Chen ^[3] ; Justine,Newson ^[4] ; Antonino,Cacace ^[1] ; Mariam,Marai ^[1] ; Andrew,Gaffney ^[1] ; Eoin,Brennan ^[1] ; Phillip,Kantharidis ^[5] ; Mark E,Cooper ^[5] ; Xavier,Leroy ^[6] ; Mauro,Perretti ^[3] ; Derek,Gilroy ^[4] ; Catherine,Godson ^[1] ; Patrick J,Guiry ^[2]

作者单位： School of Medicine, Diabetes Complications Research Centre, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland. ^[1] Centre for Synthesis and Chemical Biology, School of Chemistry, UCD Conway Institute, University College Dublin, Belfield, Dublin D04 N2E5, Ireland. ^[2] William Harvey Research Institute, Queen Mary University London, London EC1M 6BQ, U.K. ^[3] Centre for Clinical Pharmacology, University College London, London WC1E 6JF, U.K. ^[4] Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia. ^[5] Domain Therapeutics SA, 67400 Strasbourg, Illkirch, France. ^[6]